BioAge Labs (BIOA) Short-term Investments (2023 - 2026)

BioAge Labs has disclosed Short-term Investments across 3 years of filings, most recently posting $141.4 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $141.4 million, up 124.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $141.4 million (up 124.36% YoY), and the FY2025 annual result was $92.2 million, changed N/A from the prior year.
• Short-term Investments came in at $141.4 million for Q1 2026 at BioAge Labs, up from $92.2 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $141.4 million in Q1 2026 to a low of $3.3 million in Q4 2023.
• The 3-year median for Short-term Investments is $73.6 million (2025), against an average of $74.5 million.
• Peak annual rise in Short-term Investments reached 124.36% in 2026, while the deepest fall reached 124.36% in 2026.
• BioAge Labs' Short-term Investments stood at $3.3 million in 2023, then jumped by 2683.28% to $92.2 million in 2025, then soared by 53.36% to $141.4 million in 2026.
• The last three Short-term Investments figures came in at $141.4 million (Q1 2026), $92.2 million (Q4 2025), and $70.2 million (Q3 2025), per Business Quant data.